Appropriateness of Methodist Health System(MHS) Inter-facility Transfers of Traumatic Intracranial Subarachnoid Hemorrhage and Spontaneous Bleeds for Level-1 Advanced Surgical Intervention

Sponsor

Methodist Health System (Other)

Overall Status

Recruiting

CT.gov ID

NCT06136078

Collaborator

(none)

250

Enrollment

Location

Anticipated Duration (Months)

10.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Condition or Disease	Intervention/Treatment	Phase
Traumatic Intracranial Subarachnoid Hemorrhage	Other: rate of appropriate and inappropriate transfers from Methodist interfacility transfers

Detailed Description

Brain injuries are common and challenging problems faced by emergency physicians. These diagnoses may include traumatic intracerebral hemorrhage, subarachnoid hemorrhage, ruptured cerebral aneurysms, unruptured cerebral aneurysms, and arteriovenous malformations, which require neurological, neurosurgical, and/or endovascular treatment. Depending on the indication and its severity, transfer to a comprehensive stroke center for access to advanced neuro-critical care may be necessary. Comprehensive stroke centers are widely supported and have the resources and infrastructure to have in-house expert stroke providers, teams, operating rooms, and interventional radiology suites that are always available.

Study Design

Study Type:

Observational

Anticipated Enrollment :

250 participants

Observational Model:

Case-Only

Time Perspective:

Retrospective

Official Title:

Appropriateness of MHS Inter-facility Transfers of Traumatic Intracranial Subarachnoid Hemorrhage and Spontaneous Bleeds for Level-1 Advanced Surgical Intervention

Actual Study Start Date :

Jun 20, 2022

Anticipated Primary Completion Date :

Jun 20, 2024

Anticipated Study Completion Date :

Jun 20, 2024

Outcome Measures

Primary Outcome Measures

To determine the historical rate of appropriate and inappropriate Methodist interfacility transfers for patients experiencing traumatic intracranial subarachnoid hemorrhage or spontaneous bleed. [3 days]
Implementation of screening protocols and standardization for interfacility transfers may help to reduce the incidence of unnecessary transfers.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 75 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients ≥18 years old
Diagnosed with traumatic intracranial subarachnoid hemorrhage or a spontaneous bleed
Patients originating at Methodist Mansfield medical center (MMMC) or Methodist Charlton medical center(MCMC)and subsequently transferred to Methodist Dallas medical center (MDMC)

Exclusion Criteria:

Does not meet inclusion criteria defined in section 3.1

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Clinical Research Institute at Methodist Health System	Dallas	Texas	United States	75203

Sponsors and Collaborators

Methodist Health System

Investigators

Principal Investigator: Richard Meyrat, MD, Methodist Dallas Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Alan N, Kim S, Agarwal N, Clarke J, Yealy DM, Cohen-Gadol AA, Sekula RF. Inter-facility transfer of patients with traumatic intracranial hemorrhage and GCS 14-15: The pilot study of a screening protocol by neurosurgeon to avoid unnecessary transfers. J Clin Neurosci. 2020 Nov;81:246-251. doi: 10.1016/j.jocn.2020.09.050. Epub 2020 Oct 15.

Responsible Party:

Methodist Health System

ClinicalTrials.gov Identifier:

NCT06136078

Other Study ID Numbers:

101.MBSI.2022.A

First Posted:

Nov 18, 2023

Last Update Posted:

Nov 18, 2023

Last Verified:

Nov 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Subarachnoid Hemorrhage

Subarachnoid Hemorrhage, Traumatic

Hemorrhage

Study Results

No Results Posted as of Nov 18, 2023